Women's Health News

RSS

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

10 Dec 2009

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer.

10 Dec 2009

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.

9 Dec 2009

Senate rejects abortion amendment, sparking new fight

The Hill: "The Senate voted against strengthening restrictions for federal funding of abortion Tuesday evening, a development that could imperil Democrats' efforts to pass an underlying healthcare reform bill. Sen. Ben Nelson (D-Neb.), who offered the amendment, had indicated that he could support a Republican filibuster of the healthcare reform bill if the abortion language were not added to it."

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

First Edition: December 9, 2009

Today's coverage details last night's tentative agreement struck by Senate Democratic negotiators in an effort to clear the public option impasse, and a vote on an abortion amendment.

9 Dec 2009

Insurrecta Nex: Will Catholic Bishops truly defend babies?

Beginning Wednesday, December 9, Insurrecta Nex team members will travel to 13 Cathedrals in 9 states to hold vigils and press conferences. The tour will finish at the Boston Cathedral, the seat of Cardinal O'Malley, the site of decades of scandal with the Kennedy and the Kerry families.

9 Dec 2009

March of Dimes poll finds majority of pregnant women worry about birth defects

The March of Dimes polled about 1,200 moms to find out exactly what it is that caused them to lose sleep (other than the fact they were pregnant!) while they were pregnant. The results were presented today at the March of Dimes National Communications Advisory Council luncheon where experienced, practicing obstetricians and gynecologists discussed the survey results, as well as some of the frequently asked questions their patients ask.

9 Dec 2009

FRC: Taxpayers to foot the bill for abortion-on-demand

This evening, the Nelson-Hatch abortion anti-funding amendment to the "Patient Protection and Affordable Care Act" was "tabled" by a vote of 54-45, thus killing any hope to make the health care bill abortion neutral. The Nelson-Hatch amendment would have prevented government funding for elective abortion in the public option or subsidies for health plans in the government run exchange that cover elective abortion.

9 Dec 2009

Soy food beneficial for women with breast cancer

Although there is a concern regarding the safety of soy food consumption among breast cancer survivors, researchers have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence, according to a study in the December 9 issue of JAMA.

9 Dec 2009

New article in Women's Health journal emphasizes the importance of early pregnancy detection

A new article published in the peer-reviewed journal Women's Health emphasizes the importance of early pregnancy detection. Using research conducted on behalf of Church & Dwight Co. Inc., the makers of First Response, the article reviews data that shows not all at-home pregnancy tests are created equal -First Response brand pregnancy tests are more sensitive and able to detect key variants of the pregnancy hormone better than other at home pregnancy tests.

9 Dec 2009

Social isolation and stress may increase susceptibility to breast cancer, finds US study

Scientists at the University of Chicago found that rats which were prone to developing breast tumours were 3.3 times more likely to develop cancer if they were kept in isolation and suffered related stress.

9 Dec 2009

Multiple clinical study results of ABRAXANE to be presented by Abraxis BioScience

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) will be presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), being held in San Antonio, Texas from December 9 to December 13.

9 Dec 2009

FDA cleared, non-invasive prescription therapeutic device for NVP now available

PrimaBella™, the only non-invasive prescription therapeutic device cleared by the U.S. Food and Drug Administration (FDA) for the treatment of nausea and vomiting due to pregnancy (NVP), is now available. Providing a non-invasive, drug-free treatment for morning sickness, PrimaBella™ has been proven to be safe for both mother and developing baby and can offer quick relief -- the majority of patients report an immediate improvement in NVP symptoms.

9 Dec 2009

Senate vote on abortion amendment - a major hurdle to health bill - could occur today

The Washington Post reports that lawmakers in the Senate began consideration Monday "of an amendment to restrict abortion coverage" and a vote is expected today. The provision, "co-sponsored by Sens. Ben Nelson (D-Neb.) and Orrin G. Hatch (R-Utah), would bar individuals who receive federal insurance subsidies from purchasing private policies that cover elective abortions. It also would ban abortion coverage under a government plan" (Murray, 12/8).

8 Dec 2009

Young women undergoing breast cancer screening may be exposed to unnecessary harm

Breast cancer screening guidelines generally recommend mammography begin at age 40. However, based on prior national research, an estimated 34 percent of non-Hispanic black women, 30 percent of non-Hispanic white women and 22 percent of Hispanic women aged 30 to 39 have reported having a mammogram.

8 Dec 2009

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

The SAVI™ applicator for breast brachytherapy is a safe, effective therapy for breast cancer, according to a newly published study in a peer-reviewed journal.

8 Dec 2009

U.S. bishops recommend the Senate to support Nelson-Hatch-Casey amendment

The U.S. bishops have voiced support for the Nelson-Hatch-Casey Amendment to the Senate health reform bill and have asked voters to back it.

8 Dec 2009

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

Celldex Therapeutics, Inc. today announced that the Company’s first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.

8 Dec 2009

Obama urges Senators to seize 'historic opportunity'

In a meeting Sunday with Senate Democrats, President Obama urged "a fractious Democratic caucus to pull together to pass landmark health-care legislation," eschewing any policy particulars such as abortion or the public option, The Washington Post reports. A White House spokesman said Obama reminded senators of their "historic opportunity to provide stability and security for those who have insurance, affordable coverage for those who don't, and bring down the cost of health care for families, small businesses and the government" (Murray and Montgomery, 12/7).

7 Dec 2009

Women's Health News

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Senate rejects abortion amendment, sparking new fight

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

First Edition: December 9, 2009

Insurrecta Nex: Will Catholic Bishops truly defend babies?

March of Dimes poll finds majority of pregnant women worry about birth defects

FRC: Taxpayers to foot the bill for abortion-on-demand

Soy food beneficial for women with breast cancer

New article in Women's Health journal emphasizes the importance of early pregnancy detection

Social isolation and stress may increase susceptibility to breast cancer, finds US study

Multiple clinical study results of ABRAXANE to be presented by Abraxis BioScience

FDA cleared, non-invasive prescription therapeutic device for NVP now available

Senate vote on abortion amendment - a major hurdle to health bill - could occur today

Young women undergoing breast cancer screening may be exposed to unnecessary harm

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

U.S. bishops recommend the Senate to support Nelson-Hatch-Casey amendment

Celldex Therapeutics to present poster on its first antibody-drug conjugate product

Obama urges Senators to seize 'historic opportunity'

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News